Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism.

about

Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist.Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.

P2860

Q35730774-3B31DF61-EF50-49EF-96EC-329374882617 Q40196279-9B680EB3-A4E5-4680-A9E3-EF9F3EDC1939

P2860

Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism.

Item

http://www.wikidata.org/entity/Q43042778

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@en

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@nl

type

Item

label

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@en

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@nl

prefLabel

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@en

Cost-effectiveness of bemipari ...... ent of venous thromboembolism.

@nl

P1476

Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism

@en

P2093

Paolo Prandoni

http://www.w3.org/2001/XMLSchema#string

Patrizia Berto

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity.

Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.

New anticoagulants for treatment of venous thromboembolism.

Direct thrombin inhibitors: pharmacology and clinical relevance.

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.

Utilisation and safety of bemiparin, a low-molecular-weight heparin, in medical patients : a prospective, uncontrolled cohort study.

Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.

Differentiation of the low-molecular-weight heparins.

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

P304

249-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.6.3.249

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Gómez-Outes

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20528519

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism.

about

P2860

P2860

Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921